¼¼°èÀÇ ´Ü¼¼Æ÷ ´Ü¹éÁú ½ÃÀå
Single Cell Protein
»óǰÄÚµå : 1794737
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 285 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

´Ü¼¼Æ÷ ´Ü¹éÁú ¼¼°è ½ÃÀåÀº 2030³â±îÁö 155¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 100¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ´Ü¼¼Æ÷ ´Ü¹éÁú ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 7.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 155¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ È¿¸ðÁ¾Àº CAGR 9.2%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 89¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áø±ÕÁ¾ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 27¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 12.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ´Ü¼¼Æ÷ ´Ü¹éÁú ½ÃÀåÀº 2024³â¿¡ 27¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 33¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 12.1%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 3.7%¿Í 7.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ´Ü¼¼Æ÷ ´Ü¹éÁú ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

´Ü¼¼Æ÷ ´Ü¹éÁúÀÌ ½Äǰ ¹× »ç·á ½Ã½ºÅÛ¿¡¼­ È¿°úÀûÀÎ ´ë¾ÈÀ¸·Î ºÎ»óÇϰí ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

Á¶·ù, È¿¸ð, ¹ÚÅ׸®¾Æ, °õÆÎÀÌ µî ¹Ì»ý¹°¿¡¼­ ÃßÃâÇÑ ´ÜÀϼ¼Æ÷´Ü¹éÁú(SCP)Àº µ¿¹° »ç·á¿Í Àΰ£ ¿µ¾ç ¸ðµÎ¿¡¼­ Áö¼Ó°¡´ÉÇÏ°í °íÈ¿À²ÀûÀÎ ´ëü ´Ü¹éÁú·Î °¢±¤¹Þ°í ÀÖ½À´Ï´Ù. Æó±â¹° ±âÁú, ³ó¾÷ÀÜÀç¹°, »ê¾÷Á¦Ç°º°, °æÀÛ ºÒ°¡´ÉÇÑ ÅäÁö¿¡¼­ »ý»êÇÒ ¼ö ÀÖ´Â SCP´Â ½Ä·®¾Èº¸, ÅäÁöÀÌ¿ë Á¦ÇÑ, Àα¸ Áõ°¡¿¡ µû¸¥ ´Ü¹éÁú ¼ö¿ä¿¡ ´ëÇÑ Àü ¼¼°èÀûÀÎ ¿ì·Á ¼Ó¿¡¼­ À¯¸®ÇÑ À§Ä¡¿¡ ÀÖ½À´Ï´Ù. SCPÀÇ »ý»ê °øÁ¤Àº Äá, ¾îºÐ, À°·ù µî ±âÁ¸ ´Ü¹éÁú °ø±Þ¿ø¿¡ ºñÇØ ¹°, ÅäÁö, ½Ã°£ÀÌ ÈξÀ Àû°Ô ¼Ò¿äµÇ±â ¶§¹®¿¡ ÀÚ¿øÀÇ ÃÖÀûÈ­ ¹× ¼øÈ¯Çü ¹ÙÀÌ¿À°æÁ¦ ¸ðµ¨°ú ƯÈ÷ ¿¬°ü¼ºÀÌ ³ô½À´Ï´Ù.

¿µ¾çÇÐÀûÀ¸·Î SCP´Â Çʼö ¾Æ¹Ì³ë»ê, ºñŸ¹Î(ƯÈ÷ B±º), ±â´É¼º ÁöÁú°ú ÇÔ²² ³ôÀº ´Ü¹éÁú ÇÔ·®(°ÇÁ¶ Áß·® ±âÁØ 60% ÀÌ»ó)À» Á¦°øÇÕ´Ï´Ù. µû¶ó¼­ ¾ç½Ä »ç·á ¹× °¡ÃàÀÇ º¸ÃæÁ¦»Ó¸¸ ¾Æ´Ï¶ó ½Ä¹°¼º À°·ù À¯»çü, ´Ü¹éÁú °­È­ ¹Ð°¡·ç, ±â´É¼º ½Äǰ ÷°¡¹°¿¡ Ȱ¿ëÇϱ⿡µµ ÀûÇÕÇÕ´Ï´Ù. ÃÖ±Ù ¹Ì»ý¹° ±ÕÁÖ °øÇÐ ¹× ¹ßÈ¿ ±â¼úÀÇ ¹ßÀüÀ¸·Î ´Ü¹éÁú ¼öÀ², ¼ÒÈ­À², Çâ¹Ì Á߸³¼ºÀ» °³¼±ÇÏ¿© SCPÀÇ ¹üÀ§¸¦ »ç·á¿ë¿¡¼­ ½Äǰ ±â¼ú ¿µ¿ªÀ¸·Î È®ÀåÇϰí ÀÖ½À´Ï´Ù. ±â¾÷µéÀº ¸Þź°ú CO2¸¦ ź¼Ò¿øÀ¸·Î ÇÏ´Â ¹ÙÀÌ¿À¸Å½º ¹ßÈ¿, Á¤¹Ð ¹ßÈ¿, °¡½º ¹ßÈ¿ °æ·Î¸¦ Á¡Á¡ ´õ ¸¹ÀÌ ¸ð»öÇϰí ÀÖÀ¸¸ç, SCP »ý»êÀ» ±âÈĺ¯È­¸¦ °í·ÁÇÑ °üÇà°ú ź¼Ò ȸ¼ö Àü·«¿¡ ºÎÇÕÇϵµ·Ï Çϰí ÀÖ½À´Ï´Ù.

»ý»ê ±â¼ú ¹× ±âÆÇ Çõ½ÅÀº ¾î¶»°Ô ½ÃÀåÀ» Çü¼ºÇϰí Àִ°¡?

±â¼ú Çõ½ÅÀº SCP ½ÃÀå ÁøÈ­ÀÇ Á߽ɿ¡ ÀÖÀ¸¸ç, ¹ßÈ¿ °øÇÐ, ¹ÙÀÌ¿À¸®¾×ÅÍ ¼³°è ¹× ´Ù¿î½ºÆ®¸² ó¸®ÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀº ºñ¿ë È¿À²¼º°ú È®À强À» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ¸ð´ÏÅ͸µ, ÀÚµ¿È­µÈ pH ¹× ¿Âµµ Á¦¾î, ÃÖÀûÈ­µÈ Åë±â ±â¼úÀ» °®Ãá Æó¼â ·çÇÁ ¹ßÈ¿ ½Ã½ºÅÛÀ» ÅëÇØ »ý»êÀÚ´Â ¹Ì»ý¹°ÀÇ ¼ºÀåÀ» ¹Ì¼¼ Á¶Á¤ÇÏ°í ¹ÙÀÌ¿À¸Å½º ¼öÀ²À» ±Ø´ëÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¬¼Ó ¹ßÈ¿¹ýÀº ±âÁ¸ÀÇ ¹èÄ¡ ½Ã½ºÅÛÀ» ´ëüÇÏ¿© ´Ù¿îŸÀÓ°ú ¿¡³ÊÁö ¼Òºñ¸¦ ÁÙÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Æó±â¹° ó¸® ¹× »ê¾÷ Æó¼ö È帧°úÀÇ ÅëÇÕÀÌ °¡¼ÓÈ­µÇ°í ÀÖÀ¸¸ç, SCP »ý»êÀÚ´Â Æó±â¹°À» °ü¸®ÇÏ°í ´Ü¹éÁúÀÌ Ç³ºÎÇÑ ¹ÙÀÌ¿À¸Å½º¸¦ µ¿½Ã¿¡ »ý»êÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ µÎ °¡Áö ÀåÁ¡Àº ¾çÁ¶, ÆÞÇÁ ¹× Á¦Áö, À¯Á¦Ç° »ê¾÷¿¡¼­ ƯÈ÷ ¸Å·ÂÀûÀÔ´Ï´Ù.

±âÆÇÀÇ Çõ½ÅÀº SCPÀÇ ¿ëµµ¸¦ ´Ù¾çÈ­Çϰí ÅõÀÔ ºñ¿ëÀ» Àý°¨ÇÏ´Â µ¥ Áß¿äÇÑ ¿øµ¿·ÂÀÌ µË´Ï´Ù. ¿ª»çÀûÀ¸·Î ´ç¹Ð, ¿¡Åº¿Ã, Æ÷µµ´çÀÌ ¿ø·á·Î »ç¿ëµÇ¾î ¿ÔÁö¸¸, Â÷¼¼´ë SCP Ç÷§ÆûÀº ¸®±×³ë¼¿·ê·Î¿À½º°è ¹ÙÀÌ¿À¸Å½º, ³ó»ê¾÷ ÀÜ·ù¹°, ¹ÙÀÌ¿ÀµðÁ© °øÀåÀÇ ±Û¸®¼¼·Ñ, ¸ÞźÀÌ Ç³ºÎÇÑ ¹ÙÀÌ¿À°¡½º¸¦ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. ¼ö¼Ò»êÈ­±Õ°ú ¸Þź ¿µ¾ç±ÕÀ» ÀÌ¿ëÇÑ °¡½º ¹ßÈ¿´Â õ¿¬°¡½º ¹× Çø±â¼º ¼ÒÈ­ÀåÄ¡¿Í º´¼³µÈ ¹ÙÀÌ¿À¸®ÆÄÀ̳ʸ®¿¡¼­ SCP »ý»êÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº SCP »ý»êÀ» ½Ä·® ÀÛ¹° ±â¹Ý ¿ø·á·ÎºÎÅÍ ºÐ¸®ÇÒ »Ó¸¸ ¾Æ´Ï¶ó, ¼ø ¹èÃâ·® Á¦·Î ¸ñÇ¥¿¡µµ ±â¿©ÇÕ´Ï´Ù. »ý»êÀÚµéÀº CRISPR ¹× ÇÕ¼º»ý¹°ÇÐÀû µµ±¸¸¦ Ȱ¿ëÇÑ ±ÕÁÖ °øÇп¡ ÅõÀÚÇÏ¿© ±âÁú ´Ù¾ç¼º, ¾ïÁ¦Á¦ ³»¼º ¹× ¸ñÇ¥ ¿µ¾ç ÇÁ·ÎÆÄÀÏÀ» °­È­ÇÔÀ¸·Î½á ´Ù¾çÇÑ È¯°æ¿¡¼­ »ó¾÷Àû ½ÇÇà °¡´É¼ºÀ» È®ÀåÇϰí ÀÖ½À´Ï´Ù.

¹ßÈ¿ ÈÄ Ã³¸®µµ º¯È­Çϰí ÀÖ´Â ºÐ¾ß·Î, ¼¼Æ÷ÆÄ¼â, ´Ü¹éÁú ÃßÃâ, °ÇÁ¶¹æ¹ý(ºÐ¹«°ÇÁ¶, µ¿°á°ÇÁ¶, µå·³°ÇÁ¶)ÀÇ ¹ßÀüÀ¸·Î ¿µ¾çÀÇ ¿ÏÀü¼ºÀ» À¯ÁöÇϸ鼭 ´õ ±ä ÀúÀå±â°£°ú ±âÈ£¼ºÀ» ½ÇÇöÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¼±Àº ½Ä°¨, ¿Ü°ü, ¼ÒÈ­¼ºÀÌ Áß¿äÇÑ °áÁ¤ ¿äÀÎÀÌ µÇ´Â ÀÎü ½Äǰ ÀÀ¿ë ºÐ¾ß¿¡¼­ SCP°¡ ¼ö¿ëµÉ ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. »ý¸í°øÇÐ ±â¾÷ ¹× ¿¬±¸±â°ü°úÀÇ ÆÄÆ®³Ê½ÊÀ» ÅëÇØ ½Äǰ ±â¼ú ¾÷üµéÀÌ SCP Çõ½Å »ýŰ迡 ÁøÀÔÇÔ¿¡ µû¶ó, ƯÈ÷ À°·ù ´ëüǰ ¹× ´Ü¹éÁú À½·á¿Í °°Àº °íºÎ°¡°¡Ä¡ ½ÃÀå¿¡¼­ Á¦Ç° °³¹ß ÁֱⰡ °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

SCPÀÇ ¼ö¿ä ´Ùº¯È­¸¦ ÃËÁøÇÏ´Â ÀÀ¿ë ºÐ¾ß´Â?

SCP ½ÃÀåÀº ¾ç½Ä, °¡±Ý·ù, °¡Ãà, ¹Ý·Áµ¿¹° »ç·á, ±×¸®°í ÃÖ±Ù¿¡´Â Àΰ£ ½Äǰ ºÐ¾ß·Î±îÁö È®´ëµÇ´Â µî ´Ù¹æÇâÀû È®ÀåÀ» °æÇèÇϰí ÀÖ½À´Ï´Ù. ¼ö»ê »ç·á´Â ¾î·ù ¾ç½ÄÀÇ ³ôÀº ´Ü¹éÁú ¼ö¿ä¿Í ¾îºÐÀ» ´ëüÇÒ ¼ö ÀÖ´Â »ýÅÂÇÐÀû ±ä±Þ¼ºÀ¸·Î ÀÎÇØ ¿©ÀüÈ÷ Áö¹èÀûÀÎ ºÐ¾ßÀÔ´Ï´Ù. ¸Þź»êÈ­±Õ°ú È¿¸ð¿¡¼­ ÃßÃâÇÑ SCP´Â ¿¬¾î, Æ¿¶óÇǾÆ, »õ¿ì »ç·á ¹èÇÕ¿¡ Çʼö ¾Æ¹Ì³ë»êÀ» °ø±ÞÇÏ´Â µ¥ ƯÈ÷ È¿°úÀûÀÔ´Ï´Ù. ºÏ¹Ì¿Í À¯·´¿¡¼­ÀÇ ±ÔÁ¦ ½ÂÀÎÀº ¾÷°èÀÇ ½Å·Ú¸¦ ³ô¿´°í, ±âÁ¸ ±â¾÷µéÀº ¾Æ½Ã¾Æ¿Í ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¼¼°è ¾ç½Ä Çãºê¿¡ ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇØ »ç¾÷À» È®ÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, SCPÀÇ ¼ÒÈ­¼º°ú ÃÖ¼ÒÇÑÀÇ Ç׿µ¾çÀÎÀÚ·Î ÀÎÇØ »ç·á¿ä±¸À²ÀÌ Çâ»óµÇ°í, °æÀï¿ä¼Ò°¡ °­È­µÇ¾ú½À´Ï´Ù.

°¡±Ý·ù ¹× Ãà»ê ºÐ¾ß¿¡¼­ SCP´Â ´ëµÎ¹Ú°ú ¿Á¼ö¼öÀÇ ÀϺΠ´ëüÀç·Î ¹èÇÕ»ç·á¿¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. »ï¸² ÆÄ±«, ¹° »ç¿ë, À¯ÀüÀÚ º¯Çü ÀÛ¹°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¿ì·Á°¡ Ä¿Áö´Â °¡¿îµ¥, SCP´Â ¼öÀÔ »ç·á ¿ø·á¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ÁÙÀÏ ¼ö Àִ ȯ°æÀûÀ¸·Î Á߸³ÀûÀÎ ´Ü¹éÁú °ø±Þ¿øÀ¸·Î ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ç¥ÁØÈ­µÈ ¿µ¾ç ÇÁ·ÎÆÄÀÏÀº µ¿¹°ÀÇ Á¾, ¿¬·É, ¼ºÀå ´Ü°è¿¡ µû¶ó »ç·á¸¦ Á¶Á¤ÇÏ´Â Á¤¹Ð »ç·á °ø±Þ ½Ã½ºÅÛ¿¡µµ ¸Å·ÂÀûÀÔ´Ï´Ù. ¹Ý·Áµ¿¹° »ç·á Á¦Á¶¾÷üµéÀº SCP¸¦ Àú¾Ë·¹¸£±â, Àå ģȭÀûÀÎ ´Ü¹éÁú º£À̽º·Î Ȱ¿ëÇϰí ÀÖÀ¸¸ç, °³¿Í °í¾çÀ̸¦ À§ÇÑ Å¬¸° ¶óº§ Æ®·»µå¿Í ½Ä¹°¼º ¼ººÐÀ» Àü¸é¿¡ ³»¼¼¿î Æ÷¹Ä·¯¿¡ ºÎÇÕÇÏ´Â SCP¸¦ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù.

ÀÎü¿ë ½Äǰ¿¡ ´ëÇÑ Àû¿ëÀº ¾ÆÁ÷ ½ÃÀÛ ´Ü°è¿¡ ºÒ°úÇÏÁö¸¸, È¿¸ð ¹× Á¶·ù À¯·¡ SCP°¡ ÇÔÀ¯µÈ ´Ü¹éÁú ¹Ù, °­È­¸é, À¯Á¦Ç° ´ëüǰ, dz¹Ì ½º³¼ µîÀ» ÅëÇØ Á¡Â÷ ź·ÂÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ½Äǰ µî±Þ SCP´Â ¾ö°ÝÇÑ ¾ÈÀü ±âÁذú °ü´É ±âÁØÀ» ÃæÁ·ÇØ¾ß Çϸç, ¸ÀÀÇ ¸¶½ºÅ·, ÀÔ¸ÀÀÇ ÃÖÀûÈ­, ¿µ¾ç Ç¥½Ã¿¡ ´ëÇÑ ÇöÀç ÁøÇà ÁßÀÎ ¿¬±¸°¡ Á¦Ç°ÀÇ ÁÖ·ù À¯Åë ÁøÀÔÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ºÅ¸Æ®¾÷°ú ±âÁ¸ FMCG ºê·£µåµéÀº °í´Ü¹é, Àúź¼öÈ­¹°, ºñ°Ç ģȭÀûÀÎ Á¦Ç°À» À§ÇØ SCP ±â¹Ý ¿ø·á¸¦ ã°í ÀÖ½À´Ï´Ù. ¹Ì»ý¹° ½ÄǰÀÌ ¹®È­Àû »Ñ¸®°¡ µÇ´Â µ¿³²¾Æ½Ã¾Æ³ª ¾ÆÇÁ¸®Ä«ÀÇ Áö¿ª ¿ä¸®µµ SCP ±â¹Ý Á¦Ç° ÇöÁöÈ­ÀÇ ±³µÎº¸·Î Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù.

SCP¸¦ ÁÖ·ù »óǰȭ·Î À̲ô´Â ¼ºÀå Ã˸ÅÁ¦´Â ¹«¾ùÀϱî?

¼¼°è ´Ü¼¼Æ÷ ´Ü¹éÁú ½ÃÀåÀÇ ¼ºÀåÀº Áö¼Ó°¡´É¼º, ½Ä·® ¾Èº¸, »ý¸í°øÇÐÀÇ ¼ö·ÅÀ» Áß½ÉÀ¸·Î ÇÑ ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. °Å½Ã°æÁ¦Àû Â÷¿ø¿¡¼­ 2050³â±îÁö 70% ÀÌ»ó Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ¼¼°è ´Ü¹éÁú ¼ö¿ä Áõ°¡¿Í °æÀÛÁö ¸éÀû ¹× ´ã¼ö °¡¿ë¼º °¨¼Ò°¡ ¸Â¹°·Á ´ëü ´Ü¹éÁú °ø±Þ¿øÀ¸·ÎÀÇ ±¸Á¶Àû ÀüȯÀÌ ÀϾ°í ÀÖ½À´Ï´Ù. SCP´Â ¹ÙÀÌ¿À¸®¾×ÅÍ¿¡¼­ »ý»êÇÒ ¼ö ÀÖ°í ÅäÁö ¹× ¹° »ç¿ë·®À» ÃÖ¼ÒÈ­ÇÒ ¼ö Àֱ⠶§¹®¿¡ ƯÈ÷ ±âÈĺ¯È­¿¡ Ãë¾àÇÑ Áö¿ªÀ̳ª ´Ü¹éÁú °ø±ÞÀ» ¼öÀÔ¿¡ ÀÇÁ¸ÇÏ´Â Áö¿ª¿¡¼­ ±¹°¡ ´Ü¹éÁú ¾Èº¸ Àü·«¿¡ ÀÖ¾î È®Àå °¡´ÉÇÑ ¼Ö·ç¼ÇÀ¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

Á¤Ã¥Àû Ʋ°ú ±ÔÁ¦µµ SCPÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹, ³×´ú¶õµå, ½Ì°¡Æ÷¸£¿Í °°Àº ±¹°¡µéÀº ¹ßÈ¿ ±â¹Ý ´Ü¹éÁú »ý»ê¿¡ ´ëÇØ ÀçÁ¤Àû ¿ì´ë, ½Å¼ÓÇÑ ½ÂÀÎ, ÀÎÇÁ¶ó Áö¿øÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡ Áö¼Ó°¡´É¼º °ü·Ã ÅõÀÚ µ¿ÇâÀº º¥Ã³ ijÇÇÅаú ±â¾÷ÀÇ SCP ½ºÅ¸Æ®¾÷°ú ±â¼ú °³¹ßÀÚ¿¡ ´ëÇÑ ÀÚ±Ý Áö¿øÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ³ó½Äǰ ±â¾÷µéÀº ´Ü¹éÁú Æ÷Æ®Æú¸®¿À¸¦ ´Ù¾çÈ­ÇÏ°í °ø±Þ¸ÁÀÇ ¹Ì·¡¸¦ º¸ÀåÇϱâ À§ÇØ SCP »ý»êÀÚ¿Í ÇÕÀÛȸ»ç¸¦ ¼³¸³Çϰųª SCP »ý»êÀÚ¸¦ ÀμöÇÏ´Â µî ´Ù¾çÇÑ ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÚº» À¯ÀÔÀº ÆÄÀÏ·µ ±Ô¸ð¿¡¼­ »ó¾÷Àû ±Ô¸ð·ÎÀÇ ÀüȯÀ» ÃËÁøÇϰí, ƯÈ÷ »ç·á ¹× ½Äǰ¿ë SCP »ý»ê ¶óÀÎÀÇ ºñ¿ë Àý°¨ Àü·«À» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

À±¸®Àû ½Ä½À°ü, ±âÈÄ Ä£È­Àû ¼Òºñ, Á¶´Þ Åõ¸í¼º¿¡ ´ëÇÑ ¼ÒºñÀÚ ÁÖµµÀÇ º¯È­´Â SCP¸¦ ÅëÇÕÇÑ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ Çü¼ºÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¸¹Àº SCPÀÇ Å¬¸° ¶óº§, ºñ GMO, ¹«¾Ë·¯Áö, ¹«¾Ë·¯Áö Ư¼ºÀº Ç÷º½ÃÅ׸®¾ð, ä½ÄÁÖÀÇÀÚ, °Ç°­ ÁöÇâÀûÀÎ ¼ÒºñÀڵ鿡°Ô ¾îÇÊÇϰí ÀÖ½À´Ï´Ù. ±³À° Ä·ÆäÀÎ, ƯÈ÷ ǪµåÅ×Å© ¿¢½ºÆ÷, Áö¼Ó°¡´É¼º ¼­¹Ô, Á¦Ç° ¹ßÇ¥ Çà»ç µîÀ» ÅëÇØ ½Äǰ Çõ½Å¿¡ ´ëÇÑ SCPÀÇ ÀÎÁöµµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ÀÏ¹Ý ¼ÒºñÀÚÀÇ ¼ö¿ë¼ºµµ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÇØ º¼ ¶§, SCP´Â »ç·á ¹× ½Äǰ ¿ø·á·Î¼­ ¼øÈ¯Çü ¹ÙÀÌ¿À°æÁ¦, ´Ü¹éÁúÀÇ ´Ù¾çÈ­, ¹Ì»ý¹° »ý¸í°øÇÐÀÇ ÅëÇÕÀ» ÇâÇÑ Àü ¼¼°èÀûÀÎ ÃßÁø·Â¿¡ ÈûÀÔ¾î °­·ÂÇÑ »ó½Â ±Ëµµ¿¡ ¿À¸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¹®

Á¾(È¿¸ðÁ¾, Áø±ÕÁ¾, ¹ÚÅ׸®¾ÆÁ¾, Á¶·ùÁ¾), ¿ëµµ(½Äǰ ¹× À½·á ¿ëµµ, µ¿¹° »ç·á ¿ëµµ, º¸ÃæÁ¦ ¿ëµµ, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Single Cell Protein Market to Reach US$15.5 Billion by 2030

The global market for Single Cell Protein estimated at US$10.0 Billion in the year 2024, is expected to reach US$15.5 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Yeast Species, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$8.9 Billion by the end of the analysis period. Growth in the Fungi Species segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 12.1% CAGR

The Single Cell Protein market in the U.S. is estimated at US$2.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 12.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Single Cell Protein Market - Key Trends & Drivers Summarized

Why Is Single Cell Protein Emerging as a Viable Alternative in Food and Feed Systems?

Single cell protein (SCP), derived from microbial sources such as algae, yeast, bacteria, and fungi, is gaining traction as a sustainable and high-efficiency protein alternative in both animal feed and human nutrition. Its ability to be produced on non-arable land using waste substrates, agricultural residues, or industrial by-products positions it favorably amid global concerns about food security, land use limitations, and protein demand from a growing population. SCP production processes require significantly less water, land, and time compared to traditional protein sources like soy, fishmeal, or meat, making it particularly relevant in the context of resource optimization and circular bioeconomy models.

From a nutritional standpoint, SCP provides high protein content-often exceeding 60% by dry weight-along with essential amino acids, vitamins (notably B-complex), and functional lipids. This makes it suitable not only for aquaculture feed and livestock supplementation but also for use in plant-based meat analogues, protein-enriched flours, and functional food additives. Recent advancements in microbial strain engineering and fermentation technology have improved protein yield, digestibility, and flavor-neutrality, expanding SCP-s scope beyond feed applications into the domain of food technology. Companies are increasingly exploring biomass fermentation, precision fermentation, and gas fermentation routes using methane or CO2 as carbon sources, aligning SCP production with climate-smart practices and carbon capture strategies.

How Are Production Technologies and Substrate Innovations Shaping the Market?

Technological innovation lies at the heart of SCP market evolution, with rapid strides in fermentation engineering, bioreactor design, and downstream processing driving cost efficiencies and scalability. Closed-loop fermentation systems with real-time monitoring, automated pH and temperature control, and optimized aeration techniques are allowing producers to fine-tune microbial growth and maximize biomass yield. Continuous fermentation methods are replacing traditional batch systems, reducing downtime and energy consumption. Furthermore, integration with waste treatment and industrial effluent streams is gaining momentum, enabling SCP producers to simultaneously manage waste and generate protein-rich biomass. This dual benefit is particularly attractive in brewery, pulp & paper, and dairy industries.

Substrate innovation is a key driver in diversifying SCP applications and reducing input costs. While molasses, ethanol, and glucose were historically used as feedstock, new-generation SCP platforms are leveraging lignocellulosic biomass, agro-industrial residues, glycerol from biodiesel plants, and methane-rich biogas. Gas fermentation, using hydrogen-oxidizing or methanotrophic bacteria, is enabling SCP production in biorefineries co-located with natural gas or anaerobic digestion units. Such approaches not only decouple SCP production from food-crop-based feedstocks but also contribute to net-zero emission goals. Producers are investing in strain engineering-employing CRISPR and synthetic biology tools-to enhance substrate versatility, resistance to inhibitors, and target nutrient profiles, thereby expanding commercial viability in diverse environments.

Post-fermentation processing is another area undergoing transformation, with advances in cell disruption, protein extraction, and drying methods (spray drying, freeze-drying, drum drying) helping retain nutritional integrity while achieving longer shelf life and palatability. These improvements are critical for SCP-s acceptance in human food applications, where texture, appearance, and digestibility are key determinants. The entry of food technology players into SCP innovation ecosystems-through partnerships with biotech firms and research institutes-is expected to accelerate product development cycles, especially in high-value markets like meat substitutes and protein beverages.

Which Application Domains Are Catalyzing Demand Diversification for SCP?

The SCP market is experiencing multidirectional expansion, driven by uptake in aquaculture, poultry, livestock, pet food, and increasingly, human food sectors. Aquafeed remains the dominant segment due to the high protein demand in fish farming and the ecological urgency to replace fishmeal. SCP derived from methane-oxidizing bacteria and yeast is particularly effective in delivering essential amino acids for salmon, tilapia, and shrimp feed formulations. Regulatory approvals in North America and Europe have bolstered industry confidence, with established players scaling operations to serve global aquaculture hubs in Asia and Latin America. Moreover, SCP-s digestibility and minimal anti-nutritional factors enhance feed conversion ratios, reinforcing its competitive edge.

In poultry and livestock sectors, SCP is being used as a partial replacement for soybean meal and maize in compound feed blends. As consumer concerns around deforestation, water use, and genetically modified crops intensify, SCP is seen as an environmentally neutral protein source that helps reduce reliance on imported feedstocks. Its standardized nutrient profile also makes it attractive for precision feeding systems that tailor diets based on animal species, age, and growth stage. Pet food manufacturers are tapping into SCP as a hypoallergenic and gut-friendly protein base, aligning with clean-label trends and plant-forward formulations for dogs and cats.

Human food applications, while still nascent, are gaining momentum through protein bars, fortified noodles, dairy alternatives, and savory snacks incorporating yeast or algal-derived SCP. Food-grade SCP must meet stringent safety and sensory standards, and ongoing work on flavor masking, mouthfeel optimization, and nutritional labeling is helping products enter mainstream distribution. Start-ups and established FMCG brands are exploring SCP-based ingredients for high-protein, low-carb, and vegan-friendly products. Regional cuisines in Southeast Asia and Africa, where microbial foods have cultural roots, are also being leveraged as beachheads for SCP-based product localization.

What Are the Growth Catalysts Propelling SCP Toward Mainstream Commercialization?

The growth in the global single cell protein market is driven by several factors that are coalescing around sustainability, food security, and biotechnology convergence. At the macroeconomic level, rising global protein demand-expected to increase by over 70% by 2050-combined with declining arable land and freshwater availability, is creating a structural shift toward alternative protein sources. SCP-s ability to be produced in bioreactors with minimal land and water footprint is positioning it as a scalable solution in national protein security strategies, particularly in regions vulnerable to climate change or reliant on imports for protein supply.

Policy frameworks and regulatory enablers are also supporting SCP growth. Countries such as the U.S., Netherlands, and Singapore are providing funding incentives, fast-track approvals, and infrastructure support for fermentation-based protein production. At the same time, sustainability-linked investment trends are encouraging venture capital and corporate funding in SCP start-ups and technology developers. Large agri-food players are forming joint ventures or acquiring SCP producers to diversify protein portfolios and future-proof their supply chains. This influx of capital is catalyzing pilot-to-commercial scale transitions and supporting cost-reduction strategies, particularly in feed-grade and food-grade SCP production lines.

Consumer-driven shifts toward ethical eating, climate-smart consumption, and transparency in sourcing are playing a significant role in shaping demand for SCP-infused products. The clean-label, non-GMO, and allergen-free attributes of many SCP types appeal to flexitarians, vegans, and health-conscious consumers. Public acceptance is also improving due to educational campaigns and increasing visibility of SCP in food innovation narratives, particularly at food tech expos, sustainability summits, and product launch events. Collectively, these trends suggest a strong upward trajectory for SCP, both as a feed and food ingredient, underpinned by a global push toward circular bioeconomy, protein diversification, and microbial biotechnology integration.

SCOPE OF STUDY:

The report analyzes the Single Cell Protein market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Species (Yeast Species, Fungi Species, Bacteria Species, Algae Species); Application (Food & Beverages Application, Animal Feed Application, Supplements Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â